BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33462652)

  • 1. Pharmacotherapy decisions among postmenopausal women attending a group medical consultation or a one-on-one specialist consultation at an osteoporosis center: an observational cohort study.
    Liu CS; Feasel AL; Kline GA; Billington EO
    Osteoporos Int; 2021 Jul; 32(7):1421-1427. PubMed ID: 33462652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomy begets adherence: decisions to start and persist with osteoporosis treatment after group medical consultation.
    Wilton-Clark MS; Feasel AL; Kline GA; Billington EO
    Arch Osteoporos; 2020 Sep; 15(1):138. PubMed ID: 32888079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. At Odds About the Odds: Women's Choices to Accept Osteoporosis Medications Do Not Closely Agree with Physician-Set Treatment Thresholds.
    Billington EO; Feasel AL; Kline GA
    J Gen Intern Med; 2020 Jan; 35(1):276-282. PubMed ID: 31625042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 2 fracture risk estimation processes in Alberta: a cross-sectional chart review.
    Riar S; Feasel AL; Aghajafari F; Frohlich D; Symonds CJ; Kline GA; Billington EO
    CMAJ Open; 2021; 9(2):E711-E717. PubMed ID: 34162663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.
    McCloskey EV; Fitzpatrick LA; Hu MY; Williams G; Kanis JA
    Arch Osteoporos; 2019 Feb; 14(1):15. PubMed ID: 30719589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group medical consultation for osteoporosis: a prospective pilot study of patient experience in Canadian tertiary care.
    Billington EO; Feasel AL; VanDyke JL; Kline GA
    Br J Gen Pract; 2020 Nov; 70(700):e801-e808. PubMed ID: 33020167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data.
    Cui L; He T; Jiang Y; Li M; Wang O; Jiajue R; Chi Y; Xu Q; Xing X; Xia W
    Osteoporos Int; 2020 Feb; 31(2):307-316. PubMed ID: 31754756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the validity of osteoporosis and fracture risk assessment tools (IOF One Minute Test, SCORE, and FRAX) in postmenopausal Palestinian women.
    Kharroubi A; Saba E; Ghannam I; Darwish H
    Arch Osteoporos; 2017 Dec; 12(1):6. PubMed ID: 28013446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study.
    Cipriani C; Pepe J; Bertoldo F; Bianchi G; Cantatore FP; Corrado A; Di Stefano M; Frediani B; Gatti D; Giustina A; Porcelli T; Isaia G; Rossini M; Nieddu L; Minisola S; Girasole G; Pedrazzoni M
    J Endocrinol Invest; 2018 Apr; 41(4):431-438. PubMed ID: 28956296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture risk among treatment-naïve postmenopausal women with osteopenia in Greece: results from the "ACROSS" study.
    Anastasilakis AD; Makras P
    Arch Osteoporos; 2020 Oct; 15(1):163. PubMed ID: 33067646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of FRAX in postmenopausal Asian women with and without type 2 diabetes mellitus: a retrospective observational study.
    Wang C; Liu J; Xiao L; Liu D; Yan W; Hu T; Li K; Hua X; Zeng X
    J Int Med Res; 2020 Feb; 48(2):300060519879591. PubMed ID: 31617425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data.
    Bastos-Silva Y; Aguiar LB; Pinto-Neto AM; Baccaro LF; Costa-Paiva L
    Arch Osteoporos; 2016; 11():16. PubMed ID: 27067597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of pharmacotherapy in postmenopausal osteoporosis: a longitudinal observational study.
    Pluskiewicz W; Adamczyk P; Franek E; Sewerynek E; Wichrowska H; Napiórkowska L; Stuss M; Rozwandowicz A; Drozdzowska B
    Endokrynol Pol; 2019; 70(6):473-477. PubMed ID: 31909456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ten-year fracture risk by FRAX(®) of women with osteoporosis attending osteoporosis care in Hungary].
    Péntek M; Gulácsi L; Tóth E; Baji P; Brodszky V; Horváth C
    Orv Hetil; 2016 Jan; 157(4):146-53. PubMed ID: 26772827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective risk of osteoporotic fractures in patients with advanced chronic obstructive pulmonary disease.
    Gupta A; Greening NJ; Evans RA; Samuels A; Toms N; Steiner MC
    Chron Respir Dis; 2019; 16():1479972318769763. PubMed ID: 29661041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka.
    Lekamwasam S; Chandran M; Subasinghe S
    Arch Osteoporos; 2019 Mar; 14(1):33. PubMed ID: 30850909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study.
    Gonnelli S; Caffarelli C; Rossi S; Di Munno O; Malavolta N; Isaia G; Muratore M; D'Avola G; Gatto S; Minisola G; Nuti R
    Aging Clin Exp Res; 2016 Jun; 28(3):459-68. PubMed ID: 26873817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis in the Women's Health Initiative: Another Treatment Gap?
    Sattari M; Cauley JA; Garvan C; Johnson KC; LaMonte MJ; Li W; Limacher M; Manini T; Sarto GE; Sullivan SD; Wactawski-Wende J; Beyth RJ
    Am J Med; 2017 Aug; 130(8):937-948. PubMed ID: 28366425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics of postmenopausal women with osteoporosis treated with teriparatide in a real-world setting in Latin America: a subregional analysis from the Asia and Latin America Fracture Observational Study (ALAFOS).
    Cunha-Borges JL; Mier GM; Casas N; Medina A; Molina JF; García ML; Oliveria LG; Caselato MS; Cruz AC; Ippolito V; Flórez S
    Adv Rheumatol; 2019 Nov; 59(1):46. PubMed ID: 31703737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.
    LaFleur J; Rillamas-Sun E; Colón-Emeric CS; Knippenberg KA; Ensrud KE; Gray SL; Cauley JA; LaCroix AZ
    Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S78-90. PubMed ID: 26768394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.